$14.57 -0.32 (-2.15%)
12/3/2009 4:02 PM

Emergent BioSolutions, Inc. (EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

1
Member Avatar fewl10 (< 20) Submitted: 12/14/2008 9:07:11 PM : Underperform Start Price: $24.73 EBS Score: +3.78

Good grief. What a bubble

Report this Post 0 Comments

Featured Broker Partners